Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
ADR, Bausch, Bayer, biggest, biogroup, Black, Bria, Brimag, Bristol, BRMG, BS, Buffalo, Cannabic, clarity, CLGN, Codification, CollPlant, context, covenant, Depositary, Digital, distancing, escrow, fear, forfeited, Israelt, jointly, KOS, LLC, Lomb, meantime, misleading, Mobigo, Nil, NovaBay, Orange, outbreak, pandemic, Pasteur, quotient, redeem, redeemable, remotely, revaluation, sake, Sanofi, Sieczkarek, Solta, sthe, thousand, tier, today, topline, Twist, upcoming, Valeant, Wainwright, Wuhan
Removed:
attended, bear, biopharma, bridge, capitalization, capitalized, ceased, chosen, Clalit, Cohn, concrete, consisted, construction, contractor, Council, curb, dedicated, Denali, enabling, explanatory, eyefite, Fishman, footnote, genetic, gutter, Guy, Ilan, institution, intent, interpreted, Itay, Kantor, Kornberg, lecture, manager, municipal, Nevada, nominally, ophthalix, OPLI, organize, parent, Pink, Pnina, preemptive, recapitalization, recovery, recurring, referenced, Regev, retail, road, Roger, Ronen, sinking, unrealized, Weinstein
Filing tables
Filing exhibits
- 10-K Annual report
- 3.6 Certificate of Designations, Preferences and Rights of Series B Non-voting Redeemable Preferred Stock (Incorporated by Reference to Company's Current Report on Form 8-K Filed with the Sec on January 15, 2020)
- 4.3 Description of Securities
- 10.55 Memorandum of Understanding Between Wize Pharma LTD. and Resdevco, Research and Development LTD. Dated February 24, 2019
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Certification
- 31.2 Certification
- 32.1 Certification
- 32.2 Certification
- Download Excel data file
- View Excel data file
MIGI similar filings
Filing view
External links
Exhibit 23.1
Fahn Kanne & Co. Head Office 32 Hamasger Street Tel-Aviv 6721118, ISRAEL PO Box 36172, 6136101
T +972 3 7106666 F +972 3 7106660 www.gtfk.co.il |
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report dated March 30, 2020, with respect to the consolidated financial statements included in the Annual Report of Wize Pharma, Inc. on Form 10-K for the year ended December 31, 2019. We consent to the incorporation by reference of said report in the Registration Statement of Wize Pharma, Inc. on Form S-8 (File No. 333-224146).
/s/ FAHN KANNE & CO. GRANT THORNTON ISRAEL
Tel Aviv, Israel
March 30, 2020
Certified Public Accountants Fahn Kanne & Co. is the Israeli member firm of Grant Thornton International Ltd. |